Alceus Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Alceus Bio General Information

Description

Developer of synthetic chimeric antigen receptor T-cell therapies designed for solid cancers. The company's platform utilizes a multimodal architecture and artificial intelligence to design peptide medicines that program immune cells to produce therapeutics directly in the body, enabling oncology patients to access treatments that address tumor resistance and target previously undruggable malignancies.

Contact Information

Website
www.alceus.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kreston Reeves Llp, 2nd Floor
  • 168 Shoreditch High Street
  • London E1 6RA
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Kreston Reeves Llp, 2nd Floor
  • 168 Shoreditch High Street
  • London E1 6RA
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alceus Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jul-2025 Completed Startup
1. University Spin-Out 16-Oct-2024 Completed Startup
To view Alceus Bio’s complete valuation and funding history, request access »

Alceus Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alceus Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Research Technology Venture Capital Minority
Vento (Venture Capital) Venture Capital Minority
Wilbe Capital Venture Capital Minority
University of Cambridge University
To view Alceus Bio’s complete investors history, request access »

Alceus Bio FAQs

  • When was Alceus Bio founded?

    Alceus Bio was founded in 2024.

  • Where is Alceus Bio headquartered?

    Alceus Bio is headquartered in London, United Kingdom.

  • What is the size of Alceus Bio?

    Alceus Bio has 3 total employees.

  • What industry is Alceus Bio in?

    Alceus Bio’s primary industry is Drug Discovery.

  • Is Alceus Bio a private or public company?

    Alceus Bio is a Private company.

  • What is Alceus Bio’s current revenue?

    The current revenue for Alceus Bio is .

  • Who are Alceus Bio’s investors?

    Cancer Research Technology, Vento (Venture Capital), Wilbe Capital, and University of Cambridge have invested in Alceus Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process